Gene symbol | STAT3 | Synonyms | ADMIO, ADMIO1, APRF, HIES | Type of gene | protein-coding |
Chromosome | 17 | Map location | 17q21.2 | dbXrefs | |
Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
Description | signal transducer and activator of transcription 3 |
GTO ID | GTC0245 |
Trial ID | NCT02417753 |
Disease | Gastrointestinal Allergy | Ovarian Cancer |
Altered gene | STAT3 |
Therapeutic/Target gene | Target gene |
Therapy | ASO |
Treatment | ISIS 481464|Danvatirsen|ISIS-STAT3rx|AZD9150|IONIS-STAT3-2.5Rx |
Phase | Phase2 |
Recruitment status | Terminated |
Title | A Pilot Study of AZD9150, a STAT3 Antisense Oligonucleotide in Malignant Ascites |
Year | 2015 |
Country | United States |
Company sponsor | National Cancer Institute (NCI) |
Other ID(s) | 150112|15-C-0112 |
Vector information | |||
|
Cohort1: dose level 1 | |||||||||||
|
|||||||||||
Cohort2: dose level 2 | |||||||||||
|